StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30127% above fair value
$42.62+0.05 (+0.12%)

Close on Nov 17, 2026Market cap $49.66BP/E 71.0Yield –

Teva Pharmaceutical Industries Teva API (TAPI) Disposal Group by Quarter

Teva API (TAPI) Disposal Group — Total Assets Held for Sale (Q1–Q3 2025) ($M)

Teva Pharmaceutical Industries Teva API (TAPI) Disposal Group: $1,836M in Q3 2026, up 1.5% from a year earlier.

Latest, Q3 2026
1,836
Period ended Sep 30, 2026
Change on a year earlier
+1.5%
1,809 in Q3 2025
History
36 quarters
Since Q4 2017
Sources
35
Documents cited below

Where the Q3 2026 figure comes from

Source: SEC Form 10-Q (0000818686-26-000006) ↗

TAPI was classified as held-for-sale during Q1–Q3 2025 and reclassified back to held-and-used in Q4 2025 after strategic divestiture negotiations were terminated.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTeva API (TAPI) Disposal Group — Total Assets Held for Sale (Q1–Q3 2025) ($M)Year on yearSource
Q3 2026Sep 30, 20261,836+1.5%SEC Form 10-Q (0000818686-26-000006) ↗
Q2 2026Jun 30, 20261,794-2.6%SEC Form 10-Q (0001193125-26-323619) ↗
Q1 2026Mar 31, 20261,794-1.1%SEC Form 10-Q (0001193125-26-191513) ↗
Q4 2025Dec 31, 20251,842+4.0%SEC Form 10-Q (0000818686-26-000006) ↗
Q3 2025Sep 30, 20251,809+90,350.0%SEC Form 10-Q (0001193125-25-266895) ↗
Q2 2025Jun 30, 20251,842+2,569.6%SEC Form 10-Q (0001193125-25-169296) ↗
Q1 2025Mar 31, 20251,814+2,491.4%SEC Form 10-Q (0001193125-25-114889) ↗
Q4 2024Dec 31, 20241,771+2,430.0%SEC Form 10-K (0001193125-26-034532) ↗
Q3 2024Sep 30, 20242-96.1%SEC Form 10-Q (0001193125-24-252039) ↗
Q2 2024Jun 30, 202469+23.2%SEC Form 10-Q (0001193125-24-189924) ↗
Q1 2024Mar 31, 202470+600.0%SEC Form 10-Q (0001193125-24-134200) ↗
Q4 2023Dec 31, 202370+600.0%SEC Form 10-K (0001193125-25-020826) ↗
Q3 2023Sep 30, 202351+218.8%SEC Form 10-Q (0001193125-23-274495) ↗
Q2 2023Jun 30, 202356+250.0%SEC Form 10-Q (0001193125-23-201707) ↗
Q1 2023Mar 31, 202310-23.1%SEC Form 10-Q (0001193125-23-140697) ↗
Q4 2022Dec 31, 202210-47.4%SEC Form 10-K (0001193125-24-031005) ↗

Breakdown

What makes up teva API (TAPI) Disposal Group

Cite this data

StockData. (2026). Teva Pharmaceutical Industries Teva API (TAPI) Disposal Group ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/sub-tapi-hfs-assets

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?